Coverage

NewsBreak: FDA Issues New Restrictions on Fluoride Products for Young Children: What Local Families Need to Know
These actions follow a July 2025 meeting with the Reagan-Udall Foundation about the use and safety of fluoride products in children.
Read More
Thompson FDA: Reagan-Udall Foundation Roundtable Develops Recommendations for Oncology MRCTs
A roundtable convened by the Reagan-Udall Foundation for the FDA developed recommendations for oncology multi-regional clinical trials (MRCTs).
Read More
Food Safety Magazine: Regan-Udall Report Supports FDA Infant Formula Safety Efforts
The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) has released a report, titled, Infant Formula Roundtable Series Report on Cross-sector Stakeholder Insights, capturing key insights from a series of four moderated roundtable…
Read More
OncoDaily: Richard Pazdur is the New Director of the FDA’s Drug Center: New Chapter of Legacy
In 2025, Dr. Pazdur received the American Association for Cancer Research (AACR) Enduring Impact Award for Transformative Service to Cancer Science and Medicine, a recognition of his profound influence on oncology research and policy. His honors also…
Read More
Drug Discovery and Development: FDA moves against unapproved ingestible fluoride drugs for kids, citing risk-benefit concerns
FDA’s action follows a May–October review that included a Federal Register notice and public meeting organized with the Reagan-Udall Foundation and a docket to gather data on safety, clinical use and alternatives.Read more
Read More
The Association of Cannabinoid Specialists: Life Sciences Companies in a New Era: Key Strategies for Navigating the Unknown
ACS’ Board Members are actively involved in many aspects of the medical field. For example, ACS Director and attorney, Bryant Godfrey of Foley Hoag, hosted a Life Sciences conference at the firm’s Boston offices. Pictured here is Bryant interviewing the…
Read More
Food Safety Magazine: Reagan-Udall Report Explores Strengthening Cross-Sector Responses to Food Safety Threats
In light of growing threats at the intersection of human, animal, and environmental health, the Reagan-Udall Foundation has released a report outlining actionable strategies to enhance cross-sectoral coordination in response to public health incidents,…
Read More
Powell Tribune: ‘Wrongful death’ — Mother of Tranyelle Harshman sues local ketamine provider
During a July 2024 workshop hosted by the Reagan-Udall Foundation for the FDA, Dr. Gerard Sanacora of the Yale University Depression Research Program said ketamine has spurred a lot of excitement, “but I think it really speaks to the desperation of…
Read More
Data M Intelligence: United States Veterinary Antibiotics Market Set for Robust Growth Driven by Rising Animal Health Demand 2025 | Top key players - Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A.
A Reagan-Udall Foundation report in July 2025 called for modernizing regulatory pathways for animal health products to address this issue and streamline the approval process.
Read More
NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
Accordingly, NRX-100 is available for expanded access to eligible patients. More about this program can be learned from the Reagan Udall Foundation, https://navigator.reaganudall.org/, which works in conjunction with the FDA to provide public…
Read More